Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Rosiglitazone reduces urinary albumin excretion in type II diabetes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rosiglitazone reduces urinary albumin excretion in type II diabetes.
Rosiglitazone reduces urinary albumin excretion in type II diabetes. J Hum Hypertens. 2003 Jan; 17(1):7-12.
View in:
PubMed
subject areas
Administration, Oral
Aged
Albuminuria
Diabetes Mellitus, Type 2
Diabetic Angiopathies
Diabetic Nephropathies
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Hypoglycemic Agents
Kidney Function Tests
Male
Middle Aged
Reference Values
Sensitivity and Specificity
Thiazoles
Thiazolidinediones
Treatment Outcome
authors with profiles
George Bakris